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Abstract 
Background: 2,3‑Butanediol (2,3‑BDO) is a valuable chemical for industrial applications. Bacteria can produce 
2,3‑BDO with a high productivity, though most of their classification as pathogens makes them undesirable for the 
industrial‑scale production. Though Saccharomyces cerevisiae (GRAS microorganism) was engineered to produce 2,3‑
BDO efficiently in the previous studies, their 2,3‑BDO productivity, yield, and titer were still uncompetitive compared 
to those of bacteria production. Thus, we propose an industrial polyploid S. cerevisiae as a host for efficient production 
of 2,3‑BDO with high growth rate, rapid sugar consumption rate, and resistance to harsh conditions. Genetic manipu‑
lation tools for polyploid yeast had been limited; therefore, we engineered an industrial polyploid S. cerevisiae strain 
based on the CRISPR‑Cas9 genome‑editing system to produce 2,3‑BDO instead of ethanol.
Results: Endogenous genes coding for pyruvate decarboxylase and alcohol dehydrogenase were partially disrupted 
to prevent declined growth rate and  C2‑compound limitation. A bacterial 2,3‑BDO‑producing pathway was also intro‑
duced in engineered polyploid S. cerevisiae. A fatal redox imbalance was controlled through the heterologous NADH 
oxidase from Lactococcus lactis during the 2,3‑BDO production. The resulting strain (YG01_SDBN) still retained the 
beneficial traits as polyploid strains for the large‑scale fermentation. The combination of partially disrupted PDC (pyru‑
vate decarboxylase) and ADH (alcohol dehydrogenase) did not cause the severe growth defects typically found in 
all pdc‑ or adh‑deficient yeast. The YG01_SDBN strain produced 178 g/L of 2,3‑BDO from glucose with an impressive 
productivity (2.64 g/L h). When a cassava hydrolysate was used as a sole carbon source, this strain produced 132 g/L 
of 2,3‑BDO with a productivity of 1.92 g/L h.
Conclusions: The microbial production of 2,3‑BDO has been limited to bacteria and haploid laboratorial S. cerevisiae 
strains. This study suggests that an industrial polyploid S. cerevisiae (YG01_SDBN) can produce high concentration 
of 2,3‑BDO with various advantages. Integration of metabolic engineering of the industrial yeast at the gene level 
with optimization of fed‑batch fermentation at the process scale resulted in a remarkable achievement of 2,3‑BDO 
production at 178 g/L of 2,3‑BDO concentration and 2.64 g/L h of productivity. Furthermore, this strain could make 
a bioconversion of a cassava hydrolysate to 2,3‑BDO with economic and environmental benefits. The engineered 
industrial polyploid strain could be applicable to production of biofuels and biochemicals in large‑scale fermentations 
particularly when using modified CRISPR‑Cas9 tools.
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Background
The emerging platform materials of C2–C4 diol iso-
mers have been studied for production from renew-
able resources. Especially, 2,3-butanediol (2,3-BDO) is a 
promising chemical with various industrial applications 
[1]. It is used in the production of a wide range of needed 
derivatives, such as softening agents, plasticizer, poly-
ester, drugs, and cosmetics [2, 3]. In addition, 2,3-BDO 
can be used as a starting material for chemical conver-
sion, especially for production of 2-butanone (commonly 
methyl ethyl ketone or MEK) and 1,3-butadiene. MEK 
considered as an effective liquid-fuel additive and 
1,3-butadiene used to produce the synthetic rubber are 
the major building blocks in the chemical industry [4, 5]. 
It has been attempted that the promising platform mate-
rials can be produced in the engineered microorganism 
to apply large-scale fermentation. For instance, a biotech-
nology company of Genomatica (San Diego, USA) con-
structed a commercial pipeline for producing 1,4-BDO as 
much as 30,000  ton/year via the engineered Escherichia 
coli [6]. The 2,3-BDO market need is expected to reach 
74 kilotons by 2018 [7] and the estimated annual global 
market value of 2,3-BDO derivatives is approximately 43 
billion dollars [4]. Thus, global demand of industrial-scale 
production of 2,3-BDO from biomass is increasing [8].
Petroleum-based chemical processes currently domi-
nate commercial 2,3-BDO production [9]. Due to future 
global regulation of carbon dioxide emissions, scientists 
suggest that microbial production of 2,3-BDO could be 
a powerful alternative if the current low productivity 
and high production cost could be overcome. Micro-
bial production of 2,3-BDO using bacterial species such 
as Enterobacter and Klebsiella is typically done owing 
to a fast growth in nutrient-poor media and the native 
2,3-BDO-producing ability. For large-scale production, 
an inexpensive and abundant carbon source is one of the 
most important prerequisites. Therefore, previous efforts 
have used various biomass hydrolysates in the produc-
tion 2,3-BDO. In one example, a research group tried to 
delete pflB (pyruvate formate-lyase) and ptsG (glucose 
permease of the phosphotransferase system) in Entero-
bacter aerogenes to increase their use of the mixed sug-
ars in lignocellulosic hydrolysates. When a sugarcane 
bagasse hydrolysate was provided as a carbon source, the 
engineered E. aerogenes produced approximately 20 g/L 
2,3-BDO (0.395  g 2,3-BDO/g carbon source) in 72  h 
[10]. Another engineered strain of E. cloacae produced 
152 g/L 2,3-BDO within 44 h from lignocellulose-derived 
sugars [11]. In addition, other research group engineered 
Klebsiella pneumonia SDM using the strategy of random 
mutagenesis to produce 150  g/L 2,3-BDO by fed-batch 
fermentation by corn steep liquor [12]. Although these 
high performances of 2,3-BDO production are appealing, 
Enterobacter and Klebsiella species (except for K. oxy-
toca) are categorized as Risk Group 2 (RG2) pathogens 
by the World Health Organization [3]. Therefore, such 
strains might not be desirable for large-scale production 
of 2,3-BDO because of their pathogenic properties. Sci-
entists tried to reduce the virulence of these pathogenic 
bacteria by disrupting a virulence-related wabG gene 
[13] and eliminating pathogenic factors (lipopolysaccha-
rides, polysaccharide capsules, and fimbrial adhesins) 
[14]. Although their virulence factor was dramatically 
reduced, however, the concentration of 2,3-BDO was 
unfortunately decreased by 30% [13].
Instead of using a potentially pathogenic bacterial spe-
cies, we suggest using Saccharomyces cerevisiae, a spe-
cies listed as Generally Recognized As Safe (GRAS), to 
produce 2,3-BDO. It has been reported that engineered 
strains of S. cerevisiae rapidly and efficiently utilize vari-
ous sugar sources, such as xylose [15], galactose [16], 
cellobiose [17] and hydrolysates from cassava [18], ligno-
cellulose [19], and red algae [20]. Moreover, as industrial 
polyploid strains of S. cerevisiae exhibit high tolerance 
against alcohols, sugars, and harsh fermentation condi-
tions [19, 21, 22], the 2,3-BDO production process would 
be improved if the polyploid S. cerevisiae is used. None-
theless, genetic manipulation of polyploid S. cerevisiae 
has been limited, and thus, few attempts to metabolic 
engineering have been made for large-scale fermentation.
Normally, ethanol production dominates in S. cerevi-
siae sugar metabolism. This ethanol biosynthetic pathway 
needs to be metabolically replaced with a 2,3-BDO-pro-
ducing pathway to produce 2,3-BDO efficiently  (Fig.  1). 
As such, the previous research of our group made three 
perturbations to the laboratorial haploid S. cerevisiae 
genome to produce 2,3-BDO instead of ethanol from 
sugars. First, we deleted all three pyruvate decarboxylase 
isozymes (PDC 1, 5, 6), that convert pyruvate into acetal-
dehyde (the precursor of ethanol). Second, we introduced 
an enantiopure 2,3-BDO biosynthesis pathway includ-
ing α-acetolactate synthase (alsS) and α-acetolactate 
decarboxylase (alsD) from Bacillus subtilis. Third, 
endogenous 2,3-butanediol dehydrogenase (BDH1) 
was over-expressed by a strong promoter of TDH3 [23]. 
Although the resulting Pdc-deficient haploid S. cerevi-
siae strain produced 2,3-BDO as a major fermentation 
product without ethanol production, however, the engi-
neered strain grew slowly on glucose medium [24, 25]. 
The impaired growth in the Pdc-deficient haploid strain 
resulted from the depletion, or limited synthesis of cyto-
solic acetyl-CoA which is produced from acetaldehyde 
via acetate [26]. To resolve the growth defect caused by 
the limited supply of cytosolic acetyl-CoA, the heterolo-
gous gene PDC1 from Candida tropicalis was addition-
ally expressed in the Pdc-deficient haploid S. cerevisiae, 
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and the resulting strain produced 154.3  g/L 2,3-BDO. 
However, cell growth of pre-culture was still retarded 
without an ample supply of  C2 compound [27]. In 
another study, the alcohol dehydrogenase (ADH) instead 
of PDC was deleted to address the limited production of 
Acetyl-CoA. However, an accumulation of acetaldehyde 
in this Adh-deficient S. cerevisiae inhibited cell growth, 
as well [28]. Thus, industrial-scale production of 2,3-
BDO requires adjustment to these pdc- or adh-deficient 
S. cerevisiae strains.
We used an industrial polyploid S. cerevisiae obtained 
from the process of Korean liquor fermentation. It had 
been adapted to the severe environment and exhibited 
a rapid cell growth, a high sugar consumption rate, and 
a high tolerance to harsh conditions [19]. With these 
advantages for industrial large-scale production, in this 
study, the industrial S. cerevisiae was metabolically engi-
neered to produce 2,3-BDO from glucose and cassava 
hydrolysates. To minimize production of ethanol as a 
dominant metabolite of S. cerevisiae, we attempted to 
disrupt simultaneously major isozymes of PDC and ADH 
gene without decreasing cell growth on glucose as a sole 
carbon source. In addition, we introduced the 2,3-BDO 
biosynthesis pathway consisting of an endogenous BDH1 
and alsS and alsD from B. subtilis. The noxE gene from 
Lactococcus lactis was coexpressed to maintain redox 
balance under reduced ethanol production. In addition to 
the genetic perturbations, fed-batch fermentations were 
optimized to improve 2,3-BDO productivity. Cultivat-
ing an engineered industrial polyploid S. cerevisiae strain 
capable of producing 2,3-BDO in combination with 
optimization of the fed-batch fermentation will allow 
economic and environmental-friendly production of 2,3-
BDO from renewable biomass.
Results
Construction of a non‑ethanologenic polyploid S. 
cerevisiae
Disruption of pyruvate decarboxylase (PDC)
The industrial polyploid S. cerevisiae (JHS200) was genet-
ically manipulated using Cas9-based genome editing for 
the disruption of PDC as described previously [19]. A 
Fig. 1 Schematic pathway for producing 2,3‑BDO in industrial S. cerevisiae. DHAP: dihydroxyacetone phosphate; GPD 1,2: glycerol‑3‑phosphate 
dehydrogenase 1,2; LlnoxE: NADH oxidase from Lactococcus lactis; PDC 1,6: pyruvate decarboxylase 1,6; ADH 1: alcohol dehydrogenase 1; BsalsS: 
α‑acetolactate synthase from Bacillus subtilis; BsalsD: α‑acetolactate decarboxylase from B. subtilis; BDH1: 2,3‑butanediol dehydrogenase; 2,3‑BDO: 
2,3‑butanediol. Dashed arrows indicate spontaneous steps in the cell and red diagonal double line means partially disruption
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termination codon (TAA) was introduced in the middle 
of the open reading frames (ORFs) of each PDC isozymes 
(PDC1, PDC5, and PDC6). A quadruple auxotrophic 
strain (4-JHS200) [19] was used as a parental strain for 
the PDC disruption. First, PDC1, PDC5, and PDC6 were 
individually disrupted in the 4-JHS200 strain, resulting 
in single PDC-disrupted strains (4-PDC1d, 4-PDC5d, 
and 4-PDC6d). The fermentation performance of the 
single PDC-disrupted strains was evaluated. Compared 
to the parental strain (4-JHS200), there was no differ-
ence in glucose consumption rate and production of 
ethanol and glycerol for three different PDC-disrupted 
strains (4-PDC1d, 4-PDC5d, and 4-PDC6d) (Addi-
tional file 1: Figure S1). According to a previous report, 
two leftover PDC genes provide enough Pdc activity for 
the cell growth even if one of the PDC isozymes was 
deleted [29]. Second, the 4-PDC1d and 4-PDC5d strains 
were subjected to additional disruption of PDC6 using 
the same method. These resulting strains of 4-PDC16d 
and 4-PDC56d (Table  1) were cultured in YP medium 
with 50  g/L of glucose to evaluate the effects of double 
disruption of PDC genes. As the 4-PDC16d strain has 
only PDC5 and the 4-PDC56d strain has only PDC1, 
we reasoned the partial disruption of PDC genes might 
maintain cell growth rate even without the supplement 
of  C2-compounds. As previously reported, complete 
deficiency of Pdc activity in S. cerevisiae causes severe 
growth defects on glucose, and requires  C2 compounds 
such as ethanol and acetic acid for growth [25, 27, 29]. As 
shown in the fermentation results (Additional file 1: Fig-
ure S1), the 4-PDC16d and 4-PDC56d strains produced 
ethanol and glycerol slightly less than the control strain 
(4-JHS200). Based on the amount of ethanol produced, 
we speculated that the 4-PDC16d strain might have a 
lower Pdc activity than the 4-PDC56d strain or the con-
trol strain. To confirm, we measured the Pdc activities of 
the PDC-disrupted strains. The double PDC-disrupted 
strains (4-PDC16d and 4-PDC56d) showed decreased 
Pdc activities as compared to the single PDC-disrupted 
strains (4-PDC1d, 4-PDC5d, and 4-PDC6d) (Fig. 2). The 
single PDC-disrupted strains maintained Pdc activity at a 
similar or slightly lower level compared with the control 
strain (4-JHS200), and the 4-PDC16d strain exhibited the 
lowest Pdc activity (Fig.  2). Thus, the 4-PDC16d strain 
with the attenuated Pdc activity was viewed as beneficial 
as a platform strain to produce 2,3-BDO instead of etha-
nol from pyruvate. 
Deletion of alcohol dehydrogenase (ADH) with chromosomal 
expression of NADH oxidase (noxE)
In addition to PDC disruption, the expression lev-
els of alcohol dehydrogenases (ADH), which convert 
Table 1 Strains and plasmids used in this study
Strains Genotype Reference
4‑JHS200 JHS200, ura3Δ trp1Δ his3Δ leu2Δ [19]
4‑PDC1d 4‑JHS200, pdc1Δ In this study
4‑PDC5d 4‑JHS200, pdc5Δ In this study
4‑PDC6d 4‑JHS200, pdc6Δ In this study
4‑PDC16d 4‑JHS200, pdc1Δ pdc6Δ In this study
4‑PDC56d 4‑JHS200, pdc5Δ pdc6Δ In this study
YG01 4‑PDC16d, Δadh1::TDH3prom‑Llnox‑CYC1term In this study
YG01_SDB YG01, p413_SDB In this study
YG01_SDBN YG01, p413_SDB, p426TDH3_Llnox In this study
YG02 4‑PDC56d, Δadh1::TDH3prom‑Llnox‑CYC1term In this study
YG02_SDB YG02, p413_SDB In this study
Plasmids Description Reference
Cas9_Aur p414‑TEF1p‑Cas9‑CYC1t, modified Cas9 expression plasmid [19]
pRS42H Backbone plasmid for constructing guideRNA plasmids [40]
gRNA_dPDC1 pRS42H harboring PDC1 disruption gRNA cassette In this study
gRNA_dPDC5 pRS42H harboring PDC5 disruption gRNA cassette In this study
gRNA_dPDC6 pRS42H harboring PDC6 disruption gRNA cassette In this study
gRNA_dADH1 pRS42H harboring ADH1 disruption gRNA cassette In this study
p413_SDB 2,3‑BDO biosynthesis pathway (plasmid p413 harboring alsS, alsD, BDH1) [28]
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acetaldehyde to ethanol (Fig.  1), can be modulated to 
reduce ethanol production. It has been known that 
there are five isozymes (ADH1–ADH5) of alcohol dehy-
drogenase in S. cerevisiae. However, similar to the Pdc-
deficient strain, the Adh-deficient strain also had fatal 
features, such as an intracellular redox imbalance and 
deficient cell growth caused by accumulation of acetal-
dehyde [30, 31]. Therefore, ADH1 known as the major 
active enzyme out of the five isozymes would be deleted 
for reducing ethanol production [30]. Since deletion of 
the NADH-dependent ADH1 gene might cause cofactor 
imbalance, the heterologous water-forming NADH oxi-
dase (noxE) from L. lactis was simultaneously introduced 
in the middle of ADH1 chromosome. An expression cas-
sette (including TDH3 promoter and CYC1 terminator) 
of NADH oxidase was amplified from the plasmid of 
p426TDH_Llnox (Table  1). This expression cassette of 
NADH oxidase (noxE) was introduced into the middle of 
the ADH1 chromosome in the 4-PDC16d and 4-PDC56d 
strains, resulting in the deletion of ADH1 with expres-
sion of noxE. The resulting strains were named as YG01 
(4-PDC16dADH1d) and YG02 (4-PDC56dADH1d), 
respectively. The YG01 strain has intact PDC5 and 
deleted ADH1 by the chromosomally expression of noxE, 
and the YG02 strain has intact PDC1 and deficient ADH1 
by noxE expression.
These two resulting strains were cultured in YP 
medium with 40  g/L glucose. Both YG01 and YG02 
strains did not grow well, but produced a small amount of 
ethanol (< 2 g/L) (Additional file 1: Figures S2, S3). If the 
YG01 and YG02 strains lost their Adh activity by expres-
sion of noxE in the middle of the ADH1 chromosome, 
acetaldehyde would not be converted to ethanol and 
accumulated in the cell (Fig. 1). In fact, we detected that 
55  mg/L of acetaldehyde accumulated in the YG01 and 
YG02 cells, which was a 100-fold higher than that in the 
control strain (4-PDC16d) (data not shown). The accu-
mulated acetaldehyde could not be converted to ethanol 
due to the weakened Adh activity in the YG01 and YG02 
strains.
Introduction of a 2,3‑BDO pathway 
to the non‑ethanologenic yeast strains
The next step was to introduce a 2,3-BDO biosynthetic 
pathway consisting of alsS and alsD from B. subtilis 
and over-expression of endogenous BDH1 in the non-
ethanologenic strains, YG01 and YG02. Specifically, the 
plasmid p413_SDB containing alsS, alsD, and BDH1 
under strong promoters was introduced into the YG01 
and YG02 strains. Thus, carbon fluxes from pyruvate 
were redirected into α-acetolactate using α-acetolactate 
synthase encoded by alsS. Then, α-acetolactate was con-
verted into acetoin via α-acetolactate decarboxylase 
encoded by alsD. The butanediol dehydrogenase enzyme 
encoded by BDH1 converted acetoin into 2,3-BDO. The 
resulting strains were named as YG01_SDB and YG02_
SDB (Table 1).
To evaluate fermentation performance changes after 
introducing the 2,3-BDO biosynthetic pathway, the 
YG01_SDB and YG02_SDB strains were cultured in 
a flask containing YP medium with 50  g/L of glucose. 
As shown in Fig. 3, the YG01_SDB strain was found to 
be more suitable for the production of 2,3-BDO than 
the YG02_SDB strain. The glucose consumption rate 
of the YG01_SDB strain was faster than that of the 
YG02_SDB strain. As a result, the cell concentration of 
the YG01_SDB strain reached a maximum faster than 
the YG02_SDB strain (Fig. 3a, b). Moreover, the YG02_
SDB produced a small amount of ethanol (< 2 g/L) dur-
ing the fermentation. Therefore, the YG02_SDB strain 
was excluded for further experiments. As summarized 
in Table 2, the YG01_SDB strain produced 14.9 g/L of 
2,3-BDO from 50 g/L glucose within 20 h. Although a 
substantial amount (9.56 g/L) of glycerol accumulated, 
the YG01_SDB yielded 0.295 g 2,3-BDO/g glucose at a 
rate of 0.745 g/L h in a flask fermentation. After 20 h, 
the 2,3-BDO product was gradually converted into ace-
toin. Once glucose was depleted, it was likely the lack of 
NADH affected the cell growth. As such, acetoin accu-
mulated from the oxidation of 2,3-BDO into acetoin for 
regenerating NADH. As the total amount of 2,3-BDO 
and acetoin remained unchanged, we speculated that 
acetoin was not metabolized further for respiratory 
growth [28].
Fig. 2 In vitro activity assay of endogenous PDC in engineered 
S. cerevisiae strains. Assays were replicated by four independent 
experiments. 1: 4‑JHS200 (the control host strain); 2: 4‑PDC1d (only 
PDC1 disrupted); 3: 4‑PDC5d (only PDC5 disrupted); 4: 4‑PDC6d 
(only PDC6 disrupted); 5: 4‑PDC16d (PDC1 and PDC6 disrupted); 6: 
4‑PDC56d (PDC5 and PDC6 disrupted)
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Relieve of cellular redox imbalance by over‑expressed 
NADH oxidase
Typically, alcohol dehydrogenase converts two molecules 
of acetaldehyde into two moles of ethanol with consump-
tion of two moles of NADH (Fig. 1). Therefore, deleting 
the ADH1 gene caused an accumulation of NADH in 
the cytosol of the non-ethanologenic strain (YG01). The 
surplus NADH produced during 2,3-BDO biosynthe-
sis usually could be reoxidized into  NAD+ via the glyc-
erol overproduced [28]. However, the accumulation of 
glycerol obstructs the efficient production of 2,3-BDO 
as substantial amounts of a carbon source can be waste-
fully incorporated into glycerol. In addition, downstream 
processing will be complicated due to the similar chemi-
cal properties between glycerol and 2,3-BDO. To reduce 
the accumulation of glycerol, surplus NADH can be 
efficiently oxidized into  NAD+ using a water-forming 
NADH oxidase from L. lactis [32]. When the ADH1 gene 
was deleted, an expression cassette of noxE was inserted 
into the ADH1 gene site in the chromosome of the YG01_
SDB strain. However, the chromosomal single copy-num-
ber-based expression was not sufficient to compete for 
NADH with GPD (glycerol-3-phosphate dehydrogenase), 
resulting in accumulation of glycerol during 2,3-BDO 
biosynthesis (Fig.  3a). Therefore, a multi-copy-number 
plasmid (p426TDH3_Llnox) was introduced into the 
YG01_SDB strain for enhancement of NADH oxidase 
activity. The resulting strain (YG01_SDBN) indicated a 
lower glycerol yield than the parental strain (YG01_SDB) 
(Fig.  3b, c). As expected, the NADH oxidase expression 
levels were inversely proportional to the glycerol accu-
mulation levels, and proportional to 2,3-BDO production 
(Table 2). While the YG01_SDBN produced glycerol, we 
reasoned it is because of limited supply of oxygen in a 
flask fermentation.
To maintain the oxygen level, a fed-batch fermentation 
was conducted in a 1 L fermentor with the YG01_SDBN 
(Fig.  4). After the initially added glucose (100  g/L) was 
depleted, 800  g/L glucose-concentrated solution was 
intermittently fed when glucose concentration decreased 
to 20 g/L or less during the fermentation. Aeration condi-
tions were controlled at 400 rpm and a flow rate of 2 vvm. 
The dissolved oxygen level in the medium was kept below 
2.0%. The fed-batch fermentation showed two phases 
of 2,3-BDO production (Fig. 4). For the first 49 h of fer-
mentation, the YG01_SDBN strain could produce high 
concentrations of 2,3-BDO (129 g/L) with a high rate of 
2.64 g/L h, which is comparable to the fermentation per-
formances of bacteria-based processes. After 49 h of fer-
mentation, 2,3-BDO production increased to 178 g/L, at 
Fig. 3 Flask fermentation of a YG01_SDB, b YG02_SDB, and c YG01_
SDBN strains with 50 g/L glucose in YP medium. Error bars indicate 
standard deviations of three independent experiments
Table 2 Summary of the flask culture with the engineered industrial yeast strains
N/D not detected




(g/L h)DCW 2,3‑BDO Glycerol Acetoin Ethanol
YG01_SDB 2.72 14.9 9.56 3.11 N/D 0.295 0.745
YG02_SDB 2.65 14.2 9.97 2.20 1.37 0.277 0.508
YG01_SDBN 3.19 15.6 9.78 2.62 N/D 0.301 0.781
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the expense of overall productivity, which declined from 
2.64 to 1.88 g/L h, probably because of high osmotic pres-
sure caused by high concentrations of 2,3-BDO (Table 3). 
No ethanol production was observed in the fed-batch 
fermentation. With these fermentation results, the met-
abolically engineered industrial polyploid S. cerevisiae 
strain (YG01_SDBN) constructed in this work has suc-
cessfully demonstrated the possibility of producing high 
concentration of 2,3-BDO with high productivity.
Production of 2,3‑BDO from a cassava hydrolysate
To be competitive with chemical synthesis of 2,3-BDO, 
a microbial fermentation process should produce 2,3-
BDO efficiently from inexpensive substrates. As shown 
in previous studies, the same parental strain (JHS200), 
such as the engineered polyploid S. cerevisiae strain used 
in this study, has outstanding examples of fermenting a 
cellulosic hydrolysate containing substantial amounts of 
fermentation inhibitors [19]. Therefore, we evaluated the 
production of 2,3-BDO by the YG01_SDBN strain with a 
cassava hydrolysate. The batch culture of a cassava hydro-
lysate was carried out using the YG01_SDBN strain in a 
1 L scale fermentor (Fig.  5a). The cassava hydrolysates 
contained 266  g/L of glucose as a carbon source, and 
10 g/L of yeast extract and 20 g/L of peptone were added 
as a nitrogen source. During 43 h of the batch fermenta-
tion, 81.2 g/L 2,3-BDO was produced with a productivity 
of 1.89  g/L  h and a yield of 0.305  g 2,3-BDO/g glucose 
(Table 3). These results are comparable to rates of bacte-
rial fermentations of hydrolysates [33].
A fed-batch fermentation using the cassava hydrolysate 
was also performed under the same conditions of aera-
tion and feeding strategies as done in the YP medium-
based fermentation. The fed-batch fermentation of the 
cassava hydrolysate with the YG01_SDBN strain pro-
duced 132 g/L of 2,3-BDO within 69 h with a productivity 
Fig. 4 Fed‑batch fermentation of YG01_SDBN strain in a fermentor 
with YP medium
Table 3 Summary of fermentations with the YG01_SDBN strain in a fermentor
ND not detected
Fed‑batch fermentation with YP medium Up to 49 h Overall
Concentration of 2,3‑BDO (g/L) 129 178
Yield of 2,3‑BDO (g 2,3‑BDO/g glucose) 0.313 0.335
Productivity of 2,3‑BDO (g/L h) 2.64 1.88




(g/L h)DCW 2,3‑BDO Glycerol Acetoin Ethanol
Batch 9.55 81.2 51.5 1.17 N/D 0.305 1.89
Fed‑batch 8.45 132 69.4 1.19 N/D 0.324 1.92
Fig. 5 Fermentation of YG01_SDBN strain in a fermentor with a 
cassava hydrolysate. a Batch and b fed‑batch fermentation
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of 1.92 g/L h (Fig. 5b). While the production of 2,3-BDO 
continued to increase at a constant rate, the amount of 
glycerol reduced, so the 2,3-BDO yield (0.324  g 2,3-
BDO/g glucose) was greater than the yield of the batch 
fermentation (0.305  g 2,3-BDO/g glucose). Although 
the cassava hydrolysate contained a high concentration 
of glucose, the YG01_SDBN strain was able to produce 
2,3-BDO with a better yield and productivity from the 
cassava hydrolysate than from YP medium with glucose. 
Cassava has been known as an accessible substrate in 
tropical regions such as Southeast Asia and Africa, and 
its hydrolysate could be a good biomass [34]. With this 
aspect, this constructed industrial polyploid S. cerevisiae 
strain can be employed to produce 2,3-BDO with a high 
productivity using inexpensive substrates such as a cas-
sava hydrolysate.
Discussion
This study aimed that the microbial production of 2,3-
BDO would be improved by an industrial polyploid S. 
cerevisiae with high titer and productivity. As the indus-
trial yeast strain has fast growth rate, sugar metabolism, 
and resistance to fermentation inhibitors, it is suitable for 
the large-scale fermentation with a biomass hydrolysate 
in industrial fields [19]. Furthermore, if genetic modifica-
tion is successfully carried out in an industrial polyploid 
S. cerevisiae without some problems shown in previous 
studies, the engineered polyploid strain can produce 
high titer of 2,3-BDO with high productivity as much 
as engineered bacteria. Although some bacteria species 
are native producers of 2,3-BDO, most of them are clas-
sified into the Risk Group 2, which contains pathogenic 
organisms unsuitable for the large-scale fermentation. 
Possibility of fatal infection by bacteriophage should also 
be resolved in bacterial production of 2,3-BDO [35]. As 
such, the improved 2,3-BDO biosynthesis of the indus-
trial polyploid S. cerevisiae could be feasible in the pro-
duction of 2,3-BDO from renewable biomass. Though a 
polyploid S. cerevisiae has various advantages for large-
scale fermentation process, its genetic manipulation has 
been limited [36]. The CRISPR-Cas9 genome-editing 
technology could be applicable to manipulating the 
genome of industrial polyploid yeast in this study.
We hypothesized that an expression level of the pyru-
vate decarboxylase (PDC) and alcohol dehydrogenase 
(ADH) genes could be modulated to construct a non-
ethanologenic strain capable of growing on glucose 
as a sole carbon source without supplementation of a 
 C2-compound. Using an industrial polyploid S. cerevisiae 
as a parental strain, partial disruption of PDC isozymes 
was combined with partially deleted ADH isozymes to 
minimize ethanol production from glucose as a sole car-
bon source without growth inhibition. Among the three 
isozymes (PDC1, 5, 6) of pyruvate decarboxylase, the 
combination of disrupted PDC1 and PDC6 was exhib-
ited the lowest activity of PDC (Fig. 2). This partial dis-
ruption of PDC isozymes had solved the problems of 
 C2-auxotrophy and growth inhibition, which typically 
occurred in Pdc-deficient laboratorial haploid yeast 
strains [24, 27]. There has been reported chromosomal 
instability, however, caused by incomplete deletion of 
genes in polyploid S. cerevisiae. To confirm the stabil-
ity of genetic modifications, we investigated the genome 
sequence by DNA sequencing. As shown in Additional 
file  1: Figure S4, genetic manipulation of inserting the 
stop codon (TAA) has been maintained from the first 
transformants (left side) to the 60th generations strain 
(right side).
Furthermore, by eliminating only the Adh1 activity 
among the six isozymes of ADH, ethanol biosynthesis 
could be minimized without a severe metabolic bur-
den. As a result, a non-ethanologenic polyploid S. cer-
evisiae (YG01) could not produce ethanol at all and was 
barely able to grow. Partial disruption of PDC and ADH 
isozymes blocked the metabolic pathway from pyruvate 
to ethanol, resulting in the accumulation of acetalde-
hyde (55 mg/L) in the cells, which prohibited cell growth 
(Additional file  1: Figures  S2, S3). The introduction of 
the 2,3-BDO biosynthetic pathway allowed the massive 
shift of carbon flux from pyruvate to 2,3-BDO. Since the 
NADH oxidase had been introduced at the ADH1 chro-
mosome site in the process of ADH1 disruption, the level 
of NADH expression could be an indicator measured 
to confirm the disruption of ADH1 and chromosomal 
expression of noxE. To determine the expression level of 
the noxE gene, the NADH oxidase activity was measured 
for the YG01_SDB and YG02_SDB. As mentioned above, 
the YG01 and YG02 strains struggled to grow, so NADH 
oxidase activity was measured in the YG01_SDB and 
YG02_SDB strains. These strains were genetically iden-
tical to YG01 and YG02 except for additional introduc-
tion of the 2,3-BDO pathway. The chromosomally noxE 
expressed strains (YG01_SDB and YG02_SDB) showed 
higher activity than the control strain (4-JHS200), indi-
cating the confirmation of the successfully introduced 
heterologous noxE gene (Fig. 6). In conclusion, the non-
ethanologenic polyploid S. cerevisiae strains (YG01 and 
YG02), which were constructed by partially disrupting 
PDC and ADH by introduction of the heterologous noxE 
gene, are a promising platform to biosynthesize various 
products from pyruvate.
Based on the glycerol production yield of YG01_SDBN 
and YG01_SDB strain, over-expression of NADH oxidase 
relieved the redox imbalance caused by blocking the etha-
nol biosynthetic pathway which oxidized cellular NADH. 
Production of glycerol which oxidizes excessive NADH 
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into  NAD+ in the cell, however, inevitably occurred in the 
process of 2,3-BDO biosynthesis. Thus, a water-forming 
NADH oxidase was introduced to alleviate the intracel-
lular imbalance in the NADH/NAD+ ratio and to reduce 
the glycerol accumulation [27]. Under the optimized fer-
mentation conditions, the resulting engineered industrial 
strain (YG01_SDBN) produced 178 g/L 2,3-BDO with a 
maximum productivity of 2.64  g/L  h in a fed-batch fer-
mentation using glucose-based YP medium.
For a cassava hydrolysate, the YG01_SDBN strain could 
also produce 2,3-BDO while maintaining its advanta-
geous properties such as tolerance to sugars and fer-
mentation inhibitors at high concentrations, and rapid 
sugar consumption rates. This strain under fed-batch 
conditions using a cassava hydrolysate produced 132 g/L 
of 2,3-BDO with a yield of 0.324  g 2,3-BDO/g glucose. 
These results demonstrate that an engineered industrial 
polyploid S. cerevisiae might serve as a technical platform 
to produce valuable chemicals from inexpensive hydro-
lysates of renewable biomass.
Conclusions
In this study, we introduced the 2,3-BDO biosynthesis 
system (alsS, alsD from B. subtilis with over-expressed 
endogenous BDH1) into an industrial polyploid S. cerevi-
siae and produced 2,3-BDO very efficiently. Unlike pre-
vious studies [24, 27, 28], the combination of disrupted 
PDC1/PDC6 and ADH1 rerouted carbon fluxes into the 
2,3-BDO biosynthesis pathway instead of into ethanol 
production and avoided any severe growth defects. We 
successfully developed an engineered industrial poly-
ploid S. cerevisiae strain (YG01_SDB and YG02_SDB) 
able to overcome  C2-dependent growth and display 
various advantages among industrial strains when pro-
ducing 2,3-BDO. In addition, the concentration of 2,3-
BDO (178 g/L) by the engineered polyploid S. cerevisiae 
strain (YG01_SDBN) is one of the highest titer reported 
for microbial production of 2,3-BDO. While microbial 
production of 2,3-BDO has been studied in various spe-
cies of microorganism and various ways [37], attempts 
in an industrial polyploid S. cerevisiae are novel [38]. 
Besides, the results of cassava hydrolysate fermenta-
tion using the engineered polyploid S. cerevisiae are not 
inferior even compared with those of bacteria including 
K. oxytoca [39]. We expect that an engineered polyploid 
S. cerevisiae could be a powerful platform strain for pro-




Escherichia coli Top 10 (Invitrogen, Carlsbad, CA, USA) 
was used for plasmid construction and gene manipu-
lation. We grew the E. coli transformants in Lysogeny 
Broth (LB) medium with 100  μg/mL ampicillin. The 
industrial S. cerevisiae strain used in this study was found 
to be polyploid. The engineered polyploid 4-JHS200 was 
described in a previous study [19]. We cultivated the 
yeast strains in YP (10 g/L yeast extract and 20 g/L pep-
tone) medium with 0.5  μg/mL aureobasidin A (Takara, 
Shiga, Japan) or 300  μg/mL hygromycin B (Sigma-
Aldrich, St. Louis, MO, USA). Some of the engineered 
industrial strains were selected on YNB medium (6.7 g/L 
yeast nitrogen base, proper nucleotides and amino acids) 
with 0.5 μg/mL aureobasidin A and 300 μg/mL hygromy-
cin B as selection markers.
Fig. 6 In vitro activity assay of heterologous NADH oxidase expressed in engineered S. cerevisiae strains. Assays were replicated by four independent 
experiments. 1: 4‑JHS200 (the parental strain); 2: YG01_SDB (partially disrupted PDC1, PDC6, and ADH1 genes with the chromosomal expression of 
noxE gene and introduced 2,3‑BDO pathway); 3: YG02_SDB (partially disrupted PDC5, PDC6, and ADH1 genes with the chromosomal expression of 
noxE gene and introduced 2,3‑BDO pathway); 4: YG01_SDBN (partially disrupted PDC1, PDC6, and ADH1 genes with the chromosomal expression of 
noxE gene, introduced 2,3‑BDO pathway and expressed with the plasmid of p426TDH3_Llnox)
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Construction of plasmids
Table  1 summarizes the plasmids used in this study. 
Primers used to construct gBlock and repair DNA are 
presented in Additional file 1: Table S1. The Cas9 expres-
sion plasmid named Cas9_Aur was used [19]. Custom-
ized guide RNA-expressing plasmids were constructed as 
follows. First, three guide RNA-expressing cassettes with 
different sequences targeting PDC1, PDC5, and PDC6 
were synthesized to have blunt ends for SacI and KpnI 
digestion. The AccuGeneBlock service (Bioneer Co., 
Korea) synthesized these guide RNA cassettes (Addi-
tional file  1: Table  S2). Second, the synthesized guide 
RNA cassettes and plasmid pRS42H [40] were digested 
using SacI and KpnI, and ligated to each other. Third, we 
obtained the guide RNA-expressing plasmids, gRNA_
dPDC1, gRNA_dPDC5, and gRNA_dPDC6 for disrup-
tion of PDC1, PDC5, and PDC6, respectively. The guide 
RNA-expressing plasmids for the disruption of ADH1 
(gRNA_dADH1) [41] and the plasmid p426TDH3_Llnox 
were described in a previous study [32]. The constructed 
2,3-BDO pathway was introduced via plasmid p413_SDB, 
which was kindly donated by Prof. Ji-Sook, Hahn [28]. 
This plasmid p413_SDB consists of a heterogeneous alsS 
and alsD from B. subtilis and an over-expressed innate 
gene BDH1 under the control of strong constitutive pro-
moters  (PTDH3,  PTEF1, and  PTPI1, respectively), and had 
different terminators [28].
Construction of metabolically engineered S. cerevisiae 
by transformation
For the construction of PDC-disrupted strains, 4-JHS200 
harboring Cas9-Aur (Cas9-expression plasmid) was 
transformed with guide RNA plasmids and repair DNA 
fragments amplified by PCR. To introduce the 2,3-BDO 
biosynthetic pathway, plasmid p413_SDB was trans-
formed into the YG01 and YG02 strains using the Sphero-
plast Transformation Kit (BIO 101, Vista, CA, USA). To 
select the transformants, S. cerevisiae strains were culti-
vated aerobically at 30 °C in YNB medium (6.7 g/L Yeast 
Nitrogen Base, appropriate nucleotides, and amino acids) 
with 20 g/L glucose.
Activity assay of NADH oxidase and pyruvate 
decarboxylase
To measure NADH oxidase activity in a cell, a crude 
extract was prepared by growing and harvesting the 
mid-exponential phase cells (up to 1 × 108 to  109) 
grown in YNB medium-containing 20 g/L glucose, fol-
lowed by two washes of distilled water. After adding the 
protease inhibitor (Roche, Basel, Switzerland), the har-
vested cells were lysed using the yeast protein extrac-
tion reagent (Thermo Scientific, Waltham, MA, USA). 
Cells were centrifuged at 7000g and 4 °C for 20 min, and 
the supernatant was collected and tested for NADH 
oxidase activity within 3  h. The reaction mixture con-
tained 50  mM potassium phosphate buffer (pH 7.0), 
0.4 mM NADH, and 0.3 mM EDTA [42]. Enzyme activ-
ity was defined as the degree of absorbance reduction 
at 340 nm. One unit is defined as the enzyme amount 
needed to oxidize 1 μmol NADH under the conditions 
mentioned above for 3 min.
To measure the Pdc activity in the cells, we prepared a 
crude extract using the methods already described. The 
Pdc activity was assayed at 30 °C with a reaction mixture 
containing 40  mM imidazole hydrochloride buffer (pH 
6.5), 5  mM  MgCl2, 0.2  mM TPP, 17 U of alcohol dehy-
drogenase from S. cerevisiae, 0.4 mM NADH, and 50 mM 
pyruvate [43]. We initiated the reactions by adding pyru-
vate and measured the change in absorbance at 340 nm. 
One unit of activity was defined as the amount of enzyme 
oxidizing 1 μmol NADH per minute in the corresponding 
reaction conditions. The protein concentration of crude 
extracts was also determined by the Bradford method 
[44].
Culture conditions
The engineered yeast strains were pre-cultured in 5 mL 
of YP medium or YNB medium-containing 20  g/L glu-
cose at 30  °C and 250  rpm for 24  h. After growth, cells 
were harvested and transferred to 100  mL of YNB 
medium-containing 20  g/L glucose in a baffled flask at 
30 °C and 250 rpm for 24 h. These cells at mid-exponen-
tial growth state  (OD600 < 3) were harvested for use as an 
inoculum. Main batch cultures were carried out under 
microaerobic conditions in 250 mL Erlenmeyer flasks at 
30  °C and 150 rpm. Fed-batch fermentations were done 
using a 1 L bench-top fermentor (Fermentec, Cheongju, 
Korea) filled with 500 mL YP medium-containing initial 
100 g/L glucose and held at 30 °C. The pH was targeted 
to 5.5 by the intermittent addition of 5  N NaOH solu-
tion. An  O2 sensor (Mettler Toledo, Greifensee, Switzer-
land) was used to measure the dissolved oxygen (DO). 
Fed-batch cultivation was done using a fermentor oper-
ated at 400  rpm with an air flow rate of 2 vvm. During 
the fed-batch fermentation, DO levels were kept below 
2.0%. Cells prepared from the flask culture were used to 
inoculate the fed-batch culture at an initial concentration 
of 5.0  gDCW/L. When glucose concentration fell below 
20  g/L, glucose-concentrated solution (800  g/L) was 
added into the culture broth.
For the hydrolysate fermentations, 10 g/L yeast extract 
and 20 g/L peptone were added into the cassava hydro-
lysates from Changhae Ethanol Co., Ltd. Other fermenta-
tion conditions are the same as the above description.
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Preparation of cassava hydrolysates
Enzymatic hydrolysis can be used to obtain 100 g glu-
cose from 126 g of the cassava chips. Using this infor-
mation, cassava hydrolysates were prepared from 
cassava chips (starch contents equal to approximately 
72% dry weight basis) imported from Vietnam. Cassava 
chips were ground using a hammer mill and passed 
through a 1  mm screen. For liquefaction, 0.7  g/kg dry 
matter of commercial α-amylase (Termamyl SC, Novo-
zymes, Bagsvaerd, Denmark) was added, and the mash 
was heated to 100 °C and liquefied for 90 min. After the 
liquefying steps were completed, the resulting mash 
was cooled to a saccharification temperature (50  °C), 
and Spirizyme Fuel (Novozymes, Bagsvaerd, Denmark) 
was added at 0.5 g/kg dry matter. This saccharification 
step was aseptically performed for 24 h [45]. The chem-
ically saccharified cassava hydrolysates were used for 
fermentation experiments.
Determination of dry cell weight and metabolites
We measured the cell growth based on optical density 
using a spectrophotometer (OPTIZEN POP; Mecasys, 
Daejeon, Korea) set at 600  nm  (OD600). Dry cell weight 
(DCW) was estimated using a conversion factor of 0.50 
 gdry cell/L/OD600. Acetate, acetoin, ethanol, glucose, glyc-
erol, and 2,3-BDO were measured using a high-perfor-
mance liquid chromatography (1260 Infinity, Agilent, 
CO, USA) equipped with a BioRad Aminex HPX-87H 
column (300  mm 7.8  mm, 5  µm; Bio-Rad, Hercules, 
CA, USA) and a 5 mM  H2SO4 mobile phase set at a flow 
rate of 0.6 mL/min. Metabolites were quantified using a 
refractive index (RI) detector.
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